Search research articles
Contact Us
Filters
Showing results (81-90 of 741) with videos related to
Page
of 75
Sort By:
Archives of Disease in Childhood
|
April 1, 1983
Delayed visual maturation
S Harel, M Holtzman, M Feinsod
Alzheimer Disease and Associated Disorders
|
June 15, 2006
Amyloid-beta immunotherapies in mice and men
Robert P Brendza, David M Holtzman
Neuron
|
September 15, 2021
Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease
B Joy Snider, David M Holtzman
The Journal of Clinical Investigation
|
July 1, 2025
Thwarting amyloidosis: IL-17 as a disease modifier along the gut/brain axis
Wade K Self, David M Holtzman
Experimental & Molecular Medicine
|
January 3, 2024
Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies
Dong-Oh Seo, David M Holtzman
Annals of Neurology
|
February 2, 2019
Reply to "obstructive sleep apnea treatment and amyloid-β in cerebrospinal fluid"
Yo-El S Ju, David M Holtzman
Brain & Development
|
January 1, 1983
An unusual association of tuberous sclerosis and adrenogenital syndrome
M Holtzman, I Reider-Groswasser, S Harel
Immunological Reviews
|
October 24, 2024
Current insights into apolipoprotein E and the immune response in Alzheimer's disease
Peter Bor-Chian Lin, David M Holtzman
Neurobiology of Sleep and Circadian Rhythms
|
February 21, 2017
Sleep in Alzheimer's Disease - Beyond Amyloid
Jerrah Holth, Tirth Patel, David M Holtzman
Immunity
|
February 27, 2026
Immunity in Alzheimer's disease: From mechanisms to therapies
Xiaoying Chen, David M Holtzman, Marco Colonna
Page
of 75
Search research articles
Search
Showing results (81-90 of 741) with videos related to
Sort By:
Page
of 75
Archives of Disease in Childhood
|
April 1, 1983
Delayed visual maturation
S Harel, M Holtzman, M Feinsod
Alzheimer Disease and Associated Disorders
|
June 15, 2006
Amyloid-beta immunotherapies in mice and men
Robert P Brendza, David M Holtzman
Neuron
|
September 15, 2021
Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease
B Joy Snider, David M Holtzman
The Journal of Clinical Investigation
|
July 1, 2025
Thwarting amyloidosis: IL-17 as a disease modifier along the gut/brain axis
Wade K Self, David M Holtzman
Experimental & Molecular Medicine
|
January 3, 2024
Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies
Dong-Oh Seo, David M Holtzman
Annals of Neurology
|
February 2, 2019
Reply to "obstructive sleep apnea treatment and amyloid-β in cerebrospinal fluid"
Yo-El S Ju, David M Holtzman
Brain & Development
|
January 1, 1983
An unusual association of tuberous sclerosis and adrenogenital syndrome
M Holtzman, I Reider-Groswasser, S Harel
Immunological Reviews
|
October 24, 2024
Current insights into apolipoprotein E and the immune response in Alzheimer's disease
Peter Bor-Chian Lin, David M Holtzman
Neurobiology of Sleep and Circadian Rhythms
|
February 21, 2017
Sleep in Alzheimer's Disease - Beyond Amyloid
Jerrah Holth, Tirth Patel, David M Holtzman
Immunity
|
February 27, 2026
Immunity in Alzheimer's disease: From mechanisms to therapies
Xiaoying Chen, David M Holtzman, Marco Colonna
Page
of 75